CA-HAI-ROBOTICS/SKECHERS
20.2.2024 12:01:30 CET | Business Wire | Press release
Skechers USA, a leading global footwear and apparel company, turns to Hai Robotics ("Hai"), a leading global provider of Automated Storage and Retrieval Systems (ASRS), as they launch their new distribution center in Minato City, Tokyo, Japan. Using Hai’s automated goods-to-person system, Skechers is maximizing warehouse operational efficiency, fulfillment speed, and order accuracy.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240220854625/en/
A Hai Robotics Autonomous Case-handling Mobile Robot (ACR), one of 69 that pick and transport containers to fulfill orders within Skechers’ distribution center. (Photo: Business Wire)
Hai’s solution was chosen for its ability to condense storage — minimizing real estate needed — and easily adapt to changing demand, resolve labor shortage issues, and support long-term business growth.
Supported by material handling consulting company MHE Solutions, Inc., Skechers built their new facility to keep up with rapidly growing demand in the Japanese market and to advance operations that had historically relied on manually laborious tasks. Manual picking processes had been the standard to fulfill orders, but managing staff shortages coupled with expanding SKU variety contributed to high operating costs with limited outbound picking efficiency and speed. After evaluating several automation providers, Skechers ultimately determined Hai Robotics’ HaiPick System was the ideal solution for dependable and effective automated order fulfillment.
The HaiPick System is dense, adaptable to changes in consumer demand, and easily expandable as operations grow. It seamlessly integrated with other technologies in the facility to help Skechers quickly respond to customer orders. The system has also extended employee productivity while reducing physical demand on staff, helping to alleviate disruption from labor shortages.
Within Skechers’ facility, the HaiPick System covers 139,705 square feet and is operated by 69 HaiPick Autonomous Case-handling Mobile Robots (ACRs), which are integrated with Manhattan Associates' cloud-native warehouse management system (WMS). ACRs are highly intelligent, tall pieces of equipment that autonomously navigate narrow aisles of an ASRS constructed of almost any industry-standard racking or shelving with a vertical reach extending up to 32 feet. The robots pick containers off the shelving — transporting up to 8 at any given time for maximum order-batching efficiency — and deliver them to human-operated workstations.
Skechers’ HaiPick System contains 8 ergonomic workstations where operators receive clear instructions on a screen of the product and quantity to be picked to fulfill an order. The product is then scanned, and the system confirms order accuracy before the operator can proceed to the following order.
The HaiPick System is a vital part of the operational success in Skechers’ new distribution facility, helping Skechers maintain the high level of service and satisfaction their customers enjoy as they continue to grow.
“All automation projects have their challenges, but the Hai team has been a very good partner in maintaining a positive, can-do attitude and remaining committed to doing the right thing for the customer by delivering on their design,” said Sophie Houtmeyers, Vice President of Distribution Operations at Skechers, and Michael Pitt, MHE Solutions. “The Hai ACR system facilitated creative application to maximize both utilization of the warehouse floor space and hard-to-reach vertical storage space in a challenging Japanese warehousing design caused by strict fire codes. It has additionally provided productivity gains that are key to the growth of Skechers in the Japan market.”
“We are honored to help Skechers elevate the operations in their new facility and be a key part in the facility’s ability to quickly reach their customers,” said Brian Reinhart, Chief Revenue Officer at Hai Robotics U.S.A. “We are grateful for the trust that MHE and Skechers have placed in us and thrilled with the success seen so far. We will continue to work closely with MHE Solutions and Skechers to further support their warehouse automation journey and help them go above and beyond in their operational efficiency goals.”
About Hai Robotics
Hai Robotics is a leading global provider of Automated Storage and Retrieval Systems (ASRS) committed to elevating the world’s access to inventory through intelligent, fast, efficient warehouse automation that is more accessible to all facilities.
Their award-winning equipment drives highly flexible ASRS constructed of standard racking and almost any container. Hai Robotics’ solutions maximize vertical storage up to 32+ feet, reduce storage footprints up to 75%, increase workflow efficiency gains up to 4x, and improve order pick accuracy to 99.9%+.
Founded in 2016, Hai Robotics is trusted in 1,100+ projects across 40+ countries and supported by 8 offices globally. For more information, visit HaiRobotics.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240220854625/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Debiopharm’s Pre-Clinical Proof-Of-Concept Research Unveils the Potential of Novel MultiLINK Linker Technology to Overcome Tumor Resistance14.10.2026 14:00:00 CEST | Press release
Despite the remarkable progress made by ADCs, many cancer patients continue to face disease progression due to treatment resistance, tumor heterogeneity, and dose-limiting toxicities At World ADC 2026 San Diego, Debiopharm presented their latest ADC innovation to overcome these challenges with novel linker-payload technology, including modular dual payload linker MLINK DUO and modular cathepsin B-cleavable linker MLINK Select Research results with various MultiLINKTM Linker Technologies showcased broadening of vedotin-based ADC therapeutic index for MLINK Select ADCs, synergistic antitumor activity with MLINK Duo, and homogeneous DAR8 conjugation with MLINK HiSol Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standards of care to cure cancer and infectious diseases, today announced their latest research on antibody drug conjugate (ADC) research released at World ADC San Diego 2026. Results highlighted the pre-cli
Responsible AI for Children: IEEE Delivers a Trusted Safety Formula to Help Protect Kids Online14.10.2026 14:00:00 CEST | Press release
With children’s AI exposure surging, IEEE Standards Association certification helps ensure AI products for kids are ethically designed, independently tested and continually accountable for safety and well-beingFirst product certification issued to educational platform from Greek National Centre for Scientific Research The IEEE Standards Association, the global, consensus-building standards development organization of IEEE – the world’s largest technical professional organization and public charity dedicated to advancing technology for the benefit of humanity – today advanced its Responsible AI for Children (RAIC) Certification Program with the first product certified for children’s online safety. As children increasingly engage with digital and AI-enabled technologies, parents, educators, developers, and regulators want tools they can trust. IEEE’s Responsible AI for Children (RAIC) certification directly addresses these needs by translating global technical standards into a practical
Takeda Presents Phase 2/3 IgGNITE Study Results of Investigational Subcutaneous TAK-881 in Primary Immunodeficiency Disease (PID) at ESID 202614.10.2026 14:00:00 CEST | Press release
− TAK-881 met its primary endpoint, demonstrating pharmacokinetic comparability to HYQVIA® in patients 16 years and older − TAK-881 may shorten infusion times and offer the opportunity for fewer required infusion sites compared to HYQVIA with 50% less volume while maintaining up to once-monthly dosing − Adult infection outcomes and safety and tolerability profiles were comparable to HYQVIA based on descriptive analyses and consistent with established IG therapy standards Takeda (TSE:4502/NYSE:TAK) announced detailed results from the pivotal Phase 2/3 IgGNITE clinical trial (TAK-881-3001) evaluating investigational TAK-881 [Immune Globulin Subcutaneous (Human), 20% Solution (SCIG 20%) and Recombinant Human Hyaluronidase], which, if approved, has the potential to become the first facilitated SCIG 20% therapy for patients with Primary Immunodeficiency Disease (PID) administered up to once-monthly (every 3 to 4 weeks). Data in participants aged 16 years and older are featured in two late-b
Datavault AI Appoints Shareholder and Investment Executive Jeffrey Tirman to the Boardof Directors14.10.2026 13:55:00 CEST | Press release
Tirman, through his family office Abri Capital Ltd., holds 26 million DVLT shares and brings over 35 years of international investment management and corporate restructuring experience to the Company Datavault AI Inc. (“Datavault AI” or the “Company”) (Nasdaq: DVLT), an Artificial Intelligence Platform (“AIP”) company providing data monetization, credentialing, and real-world asset (“RWA”) tokenization, today announced the appointment of Jeffrey Tirman to its Board of Directors, effective as of October 12, 2026. Mr. Tirman was designated by NYIAX, Inc. (“NYIAX”) in connection with Datavault AI's recently completed acquisition of NYIAX, and he previously served on NYIAX's board of directors. As a Datavault AI Shareholder, Mr. Tirman brings both an ownership perspective and extensive management experience to the Board. Mr. Tirman has more than 35 years of international investment management experience, focused on corporate transformation, capital strategy and value creation. He has led c
EZO Reaches Financial Close on €150 Million Senior Debt Facility14.10.2026 13:21:00 CEST | Press release
Investment-grade, non-recourse financing will support the delivery of more than 3,000 charge points primarily across the whole of the UK along with additional development in Ireland. EZO has reached financial close on a €150 million investment-grade, non-recourse, senior debt facility. The funding will finance the design, installation, operation and maintenance of over 3,000 charge points, representing over 100,000 kWs of capacity, across the UK and Ireland under mostly long-term public sector “PPP-like” concessions with an attractive risk allocation between the public and private sector that will significantly advance EV infrastructure delivery, on time and to budget. These charge points are estimated to generate well in excess of £1 billion in electricity sales over the next 20 years, a portion of which will be shared with the public sector while, at the end of the concession, the chargers will revert back to the public sector. Headquartered in Ireland, EZO has expanded rapidly into
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom